Skip to main content
SpringerLink
Log in
Book cover

Progress in Anti-Cancer Chemotherapy

  • Book
  • © 2000

Overview

Editors:
  1. David Khayat

    1. Pitié-Salpétrière Hospital SOMPS, Paris Cedex 13, France

    View editor publications

    You can also search for this editor in PubMed   Google Scholar

  2. Gabriel N. Hortobagyi

    1. MD Anderson Cancer Center, Department of Breast Medical Oncology, University of Texas, Houston, USA

    View editor publications

    You can also search for this editor in PubMed   Google Scholar

  • This volumes describes selected examples of both diagnostic and therapeutic progress in areas of Hematological malignancies and common human solid tumors, with emphasis in research that has immediate or very short-term clinical application.

Part of the book series: Progress in Anti-Cancer Chemotherapy (ANTI-CANCER, volume 4)

This is a preview of subscription content, log in via an institution to check access.

Access this book

Log in via an institution
eBook USD 39.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book USD 54.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Other ways to access

Licence this eBook for your library

Institutional subscriptions

Table of contents (19 chapters)

  1. Front Matter

    Pages I-3
    Download chapter PDF

  2. Lessons from Translational Research in Oncology

    1. Front Matter

      Pages 5-5
      Download chapter PDF

    2. A Personal Perspective About the Future of Breast Cancer Research and Treatment

      • B. Fisher
      Pages 7-21

  3. Public Health Opportunities and Challenges

    1. Front Matter

      Pages 23-23
      Download chapter PDF

    2. Smoking and the Fight Against Cancer

      • M. Tubiana
      Pages 25-50

  4. Progress in Cancer Biology and Developmental Therapeutics

    1. Front Matter

      Pages 51-51
      Download chapter PDF

    2. The Role of FHIT in Human Cancer

      • Y. Pekarsky, K. Huebner, C. M. Croce
      Pages 53-61

    3. HIV, HTLV and Cancer

      • F. R. Cleghorn, R. C. Gallo
      Pages 63-83

    4. Non Steroidal Anti-Inflammatory Drugs and Cancer: Therapeutic Implications

      • L. Israël
      Pages 85-90

    5. Cancer Drugs and Cancer Drug Development for the New Millennium

      • J. Dancey, S. Arbuck
      Pages 91-109

    6. Emerging New Drugs for the Treatment of Human Lymphomas

      • A. Pinto, V. Zagonel, V. Gattei, P. Carde
      Pages 111-131

  5. Update in Clinical Management of Genitourinary Malignancies

    1. Front Matter

      Pages 133-133
      Download chapter PDF

    2. Ovarian Cancer: Current Status and Future Directions

      • R. F. Ozols
      Pages 135-144

    3. Systemic Therapy of Bladder Cancer

      • M. J. Moore
      Pages 145-152

    4. Molecular Diagnosis to Predict the Metastatic Potential of Human Prostate Cancer

      • I. J. Fidler, H. Kuniyasu, G. F. Greene, P. Troncoso, C. A. Pettaway
      Pages 153-161

    5. Early Detection and Treatment of Prostate Cancer: a Road to Patient Benefit?

      • F. H. Schröder
      Pages 163-169

    6. Prostate Cancer and Combined Androgen Blockade at All Stages of Disease

      • F. Labrie
      Pages 171-187

    7. A Biological Framework for the Development of Therapy in Prostate Cancer

      • J. Kim, C. Logothetis
      Pages 189-201

    8. The Clinical Problem of Prostate Cancer

      • C. G. Wood, A. C. von Eschenbach
      Pages 203-211

  6. Clinical Progress in Breast Cancer

    1. Front Matter

      Pages 213-213
      Download chapter PDF
Back to top

Keywords

About this book

This is the fourth volume of our series Progress in Anti-cancer Therapy. For the past four years we have taken the challenge to select each year, some of the most interesting topics on the wide field of oncology. As usual, this volume continues the tradition and covers five cancers (breast, prostate, bladder, lym­ phoma and ovarian), the role of HIV and HTLV in cancer, as well as some deve­ lopmental pharmacology and behavioral issues. This year, we have particularly focused our attention on one of the most com­ mon (although rarely addressed) cancer accounting for more than 315,00 newly diagnosed cases and 41,000 cancer-related deaths annually (Landis SH et al., 1999) : prostate cancer. Five chapters address some of the issues concerning this disease. The chap­ ter by Schroder describes the hopes and pitfalls of early detection of prostate cancer. It reviews the literature on screening studies that have been performed both in the US and in Europe. These studies suggest that cancer mortality could be reduced by screening for prostate cancer, mostly through PSA testing. However, the effectiveness of early detection still needs to be definitely confir­ med and ongoing randomized studies are described, the results of which will probably help the medical community determine the worth of PSA-based scree­ ning for prostate cancer. On the same hand, the paper from von Eschenbach is reviewing the clinical problems that are related this disease.

Editors and Affiliations

  • Pitié-Salpétrière Hospital SOMPS, Paris Cedex 13, France

    David Khayat

  • MD Anderson Cancer Center, Department of Breast Medical Oncology, University of Texas, Houston, USA

    Gabriel N. Hortobagyi

Bibliographic Information

  • Book Title: Progress in Anti-Cancer Chemotherapy

  • Editors: David Khayat, Gabriel N. Hortobagyi

  • Series Title: Progress in Anti-Cancer Chemotherapy

  • DOI: https://doi.org/10.1007/978-2-8178-0920-5

  • Publisher: Springer Paris

  • eBook Packages: Springer Book Archive

  • Copyright Information: Springer-Verlag France 2000

  • Softcover ISBN: 978-2-287-59692-6Published: 01 February 2000

  • eBook ISBN: 978-2-8178-0920-5Published: 27 November 2013

  • Edition Number: 1

  • Number of Pages: X, 270

  • Number of Illustrations: 6 b/w illustrations

  • Topics: Oncology, Cancer Research

Publish with us

Policies and ethics

Back to top

Search

Navigation